Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 3 May 2024, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Tatva Chintan Pharma Chem declined 43.30% to Rs 9.61 crore in the quarter ended March 2024 as against Rs 16.95 crore during the previous quarter ended March 2023. Sales declined 21.07% to Rs 98.27 crore in the quarter ended March 2024 as against Rs 124.51 crore during the previous quarter ended March 2023.For the full year,net profit declined 33.28% to Rs 30.35 crore in the year ended March 2024 as against Rs 45.49 crore during the previous year ended March 2023. Sales declined 7.11% to Rs 393.50 crore in the year ended March 2024 as against Rs 423.61 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales98.27124.51 -21 393.50423.61 -7 OPM %15.8813.07 -17.3314.30 - PBDT19.9213.92 43 69.1757.92 19 PBT13.6911.39 20 43.5748.37 -10 NP9.6116.95 -43 30.3545.49 -33 Powered by Capital Market - Live News

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 3 May 2024.Powered by Capital Market - Live News

Net profit of Tatva Chintan Pharma Chem declined 70.22% to Rs 3.46 crore in the quarter ended December 2023 as against Rs 11.62 crore during the previous quarter ended December 2022. Sales declined 30.18% to Rs 84.21 crore in the quarter ended December 2023 as against Rs 120.61 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales84.21120.61 -30 OPM %13.0514.85 - PBDT11.8316.61 -29 PBT5.2414.22 -63 NP3.4611.62 -70 Powered by Capital Market - Live News

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 20 January 2024.Powered by Capital Market - Live News